InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Biosimilars – Blood on the patent dance floor

Marion Webb, San Diego

With the Federal Circuit last week issuing an important decision involving biosimilars in Sandoz v Amgen, Marion Webb reports on the issues at play in the coming patent war between biosimilar and innovative companies

Ever since the Biologics Price Competition and Innovation Act (BPCIA) was enacted in 2009 as part of the Patient Protection and Affordable Care Act, uncertainty has dogged the biologics industry about how it would operate in practice....

Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

Most read articles

Latest Country Updates